Neuroblastoma: developmental biology, cancer genomics and immunotherapy

NKV Cheung, MA Dyer - Nature Reviews Cancer, 2013 - nature.com
Neuroblastoma is a solid tumour that arises from the developing sympathetic nervous
system. Over the past decade, our understanding of this disease has advanced …

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

B Hallberg, RH Palmer - Nature Reviews Cancer, 2013 - nature.com
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many
cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer …

The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report

SL Cohn, ADJ Pearson, WB London… - Journal of clinical …, 2009 - ascopubs.org
Purpose Because current approaches to risk classification and treatment stratification for
children with neuroblastoma (NB) vary greatly throughout the world, it is difficult to directly …

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

C Welch, Y Chen, RL Stallings - Oncogene, 2007 - nature.com
Neuroblastoma (NB) is one of the most common forms of cancer in children, accounting for
15% of pediatric cancer deaths. The clinical course of these tumors is highly variable and is …

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

PF Ambros, IM Ambros, GM Brodeur, M Haber… - British journal of …, 2009 - nature.com
Neuroblastoma serves as a paradigm for utilising tumour genomic data for determining
patient prognosis and treatment allocation. However, before the establishment of the …

Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy

JH Schulte, S Lim, A Schramm, N Friedrichs, J Koster… - Cancer research, 2009 - AACR
Aberrant epigenetic changes in DNA methylation and histone acetylation are hallmarks of
most cancers, whereas histone methylation was previously considered to be irreversible and …

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

S De Brouwer, K De Preter, C Kumps, P Zabrocki… - Clinical cancer …, 2010 - AACR
Purpose: Activating mutations of the anaplastic lymphoma kinase (ALK) were recently
described in neuroblastoma. We carried out a meta-analysis of 709 neuroblastoma tumors …

Overall genomic pattern is a predictor of outcome in neuroblastoma

I Janoueix-Lerosey, G Schleiermacher… - Journal of clinical …, 2009 - ascopubs.org
Purpose For a comprehensive overview of the genetic alterations of neuroblastoma, their
association and clinical significance, we conducted a whole-genome DNA copy number …

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641

DR Strother, WB London, ML Schmidt… - Journal of clinical …, 2012 - ascopubs.org
Purpose The primary objective of Children's Oncology Group study P9641 was to
demonstrate that surgery alone would achieve 3-year overall survival (OS)≥ 95% for …

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

Y Chen, RL Stallings - Cancer research, 2007 - AACR
Neuroblastoma accounts for 15% of pediatric cancer deaths, and although a few protein-
coding genes, such as MYCN, are involved with aggressive pathogenicity, the identification …